Preservative-free treatment in glaucoma: who, when, and why?

被引:35
|
作者
Stalmans, Ingeborg [1 ]
Megevand, Gordana Sunaric [2 ]
Cordeiro, M. Francesca [3 ]
Hommer, Anton [4 ]
Rossetti, Luca [5 ]
Goni, Francisco [6 ]
Heijl, Anders [7 ]
Bron, Alain [8 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Ophthalmol, B-3000 Louvain, Belgium
[2] Rothschild Mem, Geneva, Switzerland
[3] Western Eye Hosp, London, England
[4] Hera Hosp, Vienna, Austria
[5] Univ Milan, San Paolo Hosp, Eye Clin, Milan, Italy
[6] SIOVO, Barcelona, Spain
[7] Lund Univ, Dept Ophthalmol, Skane Univ Hosp, Malmo, Sweden
[8] Univ Hosp, Dept Ophthalmol, Dijon, France
关键词
Glaucoma; Intraocular pressure-lowering agents; Ocular surface; Preservative; OCULAR SURFACE DISEASE; TOPICAL ANTIGLAUCOMA MEDICATION; QUALITY-OF-LIFE; BENZALKONIUM CHLORIDE; DRY EYE; BETA-BLOCKER; TEAR FILM; CORNEAL; DRUGS; PREVALENCE;
D O I
10.5301/ejo.5000270
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To review and summarize the available literature on the effect of preservatives on the eye, to provide practical guidance for the clinical assessment of the ocular surface in glaucoma patients, and to define patient populations that might benefit from preservative-free topical intraocular pressure (IOP)-lowering agents. Methods: This manuscript is based on a combination of a literature review on preservatives and the eye and expert opinion from glaucoma specialists with an interest in ocular surface disease. Results: There is an increasingly recognized association between eyedrop preservatives and ocular surface disease. Preservative-free therapy is now available for a wide range of active compounds, although there are still some misconceptions regarding their appropriate use. For patients treated topically for glaucoma or ocular hypertension, a rough estimate could be that 20% may need treatment with topical IOP-reducing agents that are free from preservatives. Conclusions: This review provides an up-to-date account of the literature regarding preservatives and the eye, as well as suggestions and recommendations on to when to use preservative-free antiglaucoma treatment.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [31] Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages
    Hollo, Gabor
    Katsanos, Andreas
    Boboridis, Kostas G.
    Irkec, Murat
    Konstas, Anastasios G. P.
    DRUGS, 2018, 78 (01) : 39 - 64
  • [32] Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages
    Gábor Holló
    Andreas Katsanos
    Kostas G. Boboridis
    Murat Irkec
    Anastasios G. P. Konstas
    Drugs, 2018, 78 : 39 - 64
  • [33] Efficacy and tolerability of a preservative-free 0.005% latanoprost in glaucoma patients: a prospective crossover study
    Martin Baiza-Duran, Leopoldo
    Olvera Montano, Oscar
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [34] COMPATIBILITY OF A PRESERVATIVE-FREE SUNSCREEN - REPLY
    ABERER
    ALLERGOLOGIE, 1994, 17 (07) : 340 - 340
  • [35] Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
    Wonseok Lee
    Sunghoon Lee
    HyoungWon Bae
    Chan Yun Kim
    Gong Je Seong
    BMC Ophthalmology, 17
  • [36] Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
    Lee, Wonseok
    Lee, Sunghoon
    Bae, HyoungWon
    Kim, Chan Yun
    Seong, Gong Je
    BMC OPHTHALMOLOGY, 2017, 17
  • [37] Preservative-free flu vaccine for infants
    Fox, S
    INFECTIONS IN MEDICINE, 2002, 19 (11) : 506 - 506
  • [38] The Efficacy and Safety of Preservative-containing and Preservative-free Brimonidine-Timolol Fixed Combination in Normal Tension Glaucoma
    Kim, Bo Kyung
    Kim, Si Nae
    Kim, Joon Mo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2021, 62 (10): : 1407 - 1414
  • [39] Comparison of the efficacy and safety of preservative-free dorzolamide and dorzolamide with preservative
    Rusk, C
    Liss, R
    Clineschmidt, C
    Getson, A
    Shedden, A
    Adamsons, I
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S664 - S664
  • [40] Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
    Chabi, A.
    Baranak, C.
    Lupinacci, R.
    Herring, W. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (07) : 577 - 586